Clinical Trial Update: Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome

View source ↗

Summary

This clinical trial update discusses the timing of optimal platelet inhibition after acute coronary syndrome, sponsored by Hôpital de la Timone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: Hôpital de la Timone | Conditions: Acute Coronary Syndrome, Coronary Stenting | Status: UNKNOWN